Where I see patients (2)
My reviews
Selected research
-
Somatic alterations of TP53 and MDM2 associated with response to enfortumab vedotin in patients with advanced urothelial cancer.
Frontiers in oncology
-
Theranostic Targeting of CUB Domain-Containing Protein 1 (CDCP1) in Multiple Subtypes of Bladder Cancer.
Clinical cancer research : an official journal of the American Association for Cancer Research
-
Treatment of prostate cancer with CD46 targeted 225Ac alpha particle radioimmunotherapy.
Clinical cancer research : an official journal of the American Association for Cancer Research
Contact me
- Request appointment
- Refer a patient
- (415) 476-4616
4.9